Provided by Tiger Trade Technology Pte. Ltd.

Revelation Biosciences, Inc.

1.65
+0.180012.24%
Post-market: 1.62-0.0300-1.82%19:59 EST
Volume:720.90K
Turnover:1.12M
Market Cap:2.44M
PE:-0.01
High:1.67
Open:1.49
Low:1.41
Close:1.47
52wk High:54.48
52wk Low:1.41
Shares:1.48M
Float Shares:581.00K
Volume Ratio:1.47
T/O Rate:124.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-120.0200
EPS(LYR):-1,052.1977
ROE:-118.88%
ROA:-52.64%
PB:0.22
PE(LYR):0.00

Loading ...

Revelation Biosciences Raises $7.3 Million Through Unregistered Warrant Exercise

Reuters
·
Jan 29

Revelation Biosciences Inc trading halted, news pending

TIPRANKS
·
Jan 28

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Jan 28

Revelation Biosciences Announces 1-for-4 Reverse Stock Split

Reuters
·
Jan 26

Revelation Biosciences Raises $11 Million Through Immediate Warrant Exercise

Reuters
·
Jan 26

Why Did Revelation Biosciences (REVB) Stock Jump Over 25% After-Hours?

Benzinga_recent_news
·
Jan 23

Revelation reaches agreement with FDA on Gemini approval pathway

TIPRANKS
·
Jan 21

Revelation Biosciences Unveils Positive Clinical Data for Gemini in Kidney Disease Treatment

Reuters
·
Jan 14

Revelation Biosciences Grants 90,000 RSUs to New Employee

Reuters
·
Jan 13

Revelation Biosciences Prepares Gemini for Late-Stage Acute Kidney Injury Trials

Reuters
·
Dec 04, 2025

Revelation Says On Track for FDA Meeting Later This Year

MT Newswires Live
·
Nov 21, 2025

Revelation Biosciences on track for end-of-phase 1 meeting later this year

TIPRANKS
·
Nov 20, 2025

Revelation Biosciences Advances Gemini Toward FDA Review for Acute Kidney Injury

Reuters
·
Nov 20, 2025

Revelation Biosciences Inc. Q3 EPS USD -1.77

Reuters
·
Nov 20, 2025

Revelation Biosciences Q3 EPS $(1.77) Misses $(1.33) Estimate

Benzinga
·
Nov 07, 2025

Revelation Biosciences reports $1.9 million net loss for Q3 2025

Reuters
·
Nov 07, 2025

BRIEF-Revelation Biosciences Inc. Q3 EPS USD -1.77

Reuters
·
Nov 07, 2025

Revelation Biosciences Inc expected to post a loss of $1.33 a share - Earnings Preview

Reuters
·
Nov 04, 2025

Revelation Biosciences Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Sep 24, 2025

Revelation Biosciences files to sell 13.07M shares of common stock for holders

TIPRANKS
·
Sep 17, 2025